Insider Transactions Reported by 24 Insiders of IO Biotech, Inc.

Symbol
IOBT on Nasdaq
Location
Copenhagen, Denmark

Insiders trading volume in the past year

IO Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lundbeckfond Invest A/S Director, 10%+ Owner $14,438,960 09 Aug 2023
Novo Holdings A/S 10%+ Owner $10,709,987 25 Jul 2024
Vivo Capital IX, LLC 10%+ Owner $9,510,598 09 Aug 2023
HBM Healthcare Investments (Cayman) Ltd. 10%+ Owner $2,784,714 09 Nov 2021
Claus A. Andersson Director $1,854,192 09 Nov 2021
Kurma Partners 10%+ Owner $645,248 09 Aug 2023
Vanessa Malier Director $445,544 09 Nov 2021
Amy Sullivan Chief Financial Officer $70,041 02 Apr 2025
Mai-Britt Zocca Chief Executive Officer, Director $61,911 02 Apr 2025
Qasim Iftikhar Ahmad Chief Medical Officer $26,553 02 Apr 2025
Heidi Hunter Director $20,884 +$20,885 05 Jun 2025
Devin Whittemore Smith General Counsel $13,720 02 Apr 2025
Emmanuelle Coutanceau Director 04 Nov 2021
Jack Nielsen Director 08 Jun 2023
Priyanka Belawat Director 04 Nov 2021
Peter Hirth Director 05 Jun 2025
Keith A. Vendola Chief Financial Officer 04 Nov 2021
Eva Ehrnrooth Chief Medical Officer 20 Mar 2023
Muhammad Al-Hajj Chief Scientific Officer 20 Mar 2023
Christian E. Elling Director 05 Jun 2025
Helen Louise Collins Director 05 Jun 2025
David Smith V. Director 05 Jun 2025
Kathleen Sereda Glaub Director 05 Jun 2025
Brian Burkavage Chief Accounting Officer 02 Apr 2025

Recent Insider Transactions by Companies or Individuals for IO Biotech, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.